| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.5M | +0.4% |
| Cost of Revenue | $21.9M | +13.7% |
| Gross Profit | $533K | -82.8% |
| R&D Expense | $41.1M | -15.6% |
| SG&A Expense | $34.2M | +14.3% |
| Operating Income | -$74.8M | +1.0% |
| Interest Expense | $8.4M | -24.1% |
| Income Tax | $0 | — |
| Net Income | -$78.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.6M | -1.5% |
| Short-term Investments | $33.7M | +0.0% |
| Inventory | $4.4M | -49.6% |
| Current Assets | $91.4M | -29.7% |
| Total Assets | $100.4M | -27.3% |
| Current Liabilities | $38.8M | +125.1% |
| Long-term Debt | $34.7M | -15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.5M | +13.8% |
| Investing Cash Flow | $32.8M | -63.4% |
| Financing Cash Flow | $26.8M | +31.7% |
| -30.2% |
| EPS (Basic) | -$0.12 | -9.1% |
| EPS (Diluted) | -$0.12 | -9.1% |
| Total Liabilities |
| $79.3M |
| +22.5% |
| Stockholders' Equity | -$16.6M | -146.2% |